Oneness announces on behalf of Cotton Field Organic Farm Inc., a major subsidiary, for a resolution by BODs on convening the 2021 Annual Shareholders' Meeting	2021-02-24
	Oneness received the letter from MOHW informing that ON101 for DFUs has obtained the new drug approval and its drug certificate will be notified for receipt.	2021-02-24
	Oneness submits an IND to US FDA on a phase II clinical trial on severe asthma of FB704A, a mAb developed from its own platform.	2021-02-15
	Oneness will not proceed with the ON101 Phase3 clinical trial (ON101CLCT04) application with BfArM of Germany based on strategic consideration.	2021-02-09
	Oneness Biotech Co.,LTD receives a U.S. patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on the developing new drug: ON101 Cream.	2021-02-02
	Oneness Biotech Co.,LTD receives a European patent on antagonistic PDL1 aptamers.	2021-01-29